At the upcoming 18th edition of the European Multidisciplinary Congress on Urological Cancers (EMUC26), which will take place from 5 to 8 November 2026, leading experts in genito-urological oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology will examine the current practices, identify the best therapies, and review emerging innovations in genitourinary (GU) cancers treatment and management. Day 4 of EMUC26 kicked off early with Plenary Session ‘Renal cancer: Local and systemic treatment in metastatic disease’, ... “Cancer survivorship starts at the time of diagnosis, through the balance of an individual’s life. GU cancer survivors include... What matters in germline-somatic interplay and testing pathways in precision oncology? Plenary Session 7 “Familial cancers: molecular diagnostics, management...Dear friends and colleagues,
The congress
News and reports
Treatment advances for metastatic renal cancer
Beyond survival: The road ahead for patients
Germline-somatic interplay and testing pathways: What matters most?
